(Q37133086)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Duck Jin Hwang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Hyuncheol Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Se Joon Woo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Ji Hyun Park

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sunyoung Park

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Kyu Hyung Park

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

4 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

Journal of Ocular Pharmacology and Therapeutics

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

612-618

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

2 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Intravitreal injection of methotrexate in an experimental rabbit model: determination of pharmacokinetics

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Intravitreal therapy for neovascular age-related macular degeneration and inter-individual variations in vitreous pharmacokinetics

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Ranibizumab for neovascular age-related macular degeneration

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Half-life and vitreous clearance of trifluorothymidine after intravitreal injection in the rabbit eye

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Anatomic and pharmacokinetic properties of intravitreal bevacizumab and ranibizumab after vitrectomy and lensectomy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

One-year results of intravitreal bevacizumab as an adjunct to trabeculectomy for neovascular glaucoma in eyes with previous vitrectomy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

The effect of bevacizumab for anterior segment neovascularization after silicone oil removal in eyes with previous vitreoretinal surgery

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Vitreous VEGF clearance is increased after vitrectomy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Pharmacokinetics of intravitreal ranibizumab (Lucentis).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Pharmacokinetics and retinal distribution of ranibizumab, a humanized antibody fragment directed against VEGF-A, following intravitreal administration in rabbits

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Penetration of bevacizumab through the retina after intravitreal injection in the monkey.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Ocular fluorescein kinetics before and after vitrectomy on swine

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Pharmacokinetics of intravitreal vancomycin in normal and infected rabbit eyes

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3757534

Pharmacokinetics of newer cephalosporins after subconjunctival and intravitreal injection in rabbits

3 September 2018

1 reference

12 December 2020

Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys

1 reference

12 December 2020

Injection site and pharmacokinetics after intravitreal injection of immunoglobulin G

1 reference

12 December 2020

Clearance of intravitreal voriconazole

1 reference

12 December 2020

Clearance and distribution of ciprofloxacin after intravitreal injection

1 reference

12 December 2020

Amphotericin clearance in vitrectomized versus nonvitrectomized eyes

1 reference

12 December 2020

The clearance of intravitreal triamcinolone acetonide

1 reference

12 December 2020

Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes

1 reference

12 December 2020

The pharmacokinetics of rituximab following an intravitreal injection

1 reference

12 December 2020

Clearance of intravitreal fluorouracil. Normal and aphakic vitrectomized eyes

1 reference

12 December 2020

Pharmacokinetics of intravitreal bevacizumab (Avastin)

1 reference

12 December 2020

INTRAOCULAR PHARMACOKINETICS AFTER A SINGLE INTRAVITREAL INJECTION OF 1.5 mg VERSUS 3.0 mg OF BEVACIZUMAB IN HUMANS

1 reference

12 December 2020

Pharmacokinetic comparison of ketorolac after intracameral, intravitreal, and suprachoroidal administration in rabbits

1 reference

12 December 2020

Identifiers

DOI

10.1089/JOP.2013.0009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

23735192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23735192%20AND%20SRC:MED&resulttype=core&format=json